The newest miracle drug for weight loss is changing the lives of thousands of people who have battled obesity for extended periods of time.These GLP-1 medications are also treating or preventing the diseases that go with long term obesity: Diabetes, Heart Disease, Joint replacements, Arthritis, Sleep Apnea, and Alzheimers Disease
However, peptides with little clinical research were on the chopping block due to concerns of impurities and dangerous side effects linked to compounded treatments
By promoting GH release, Tesamorelin may possibly enhance lipolysis, reduce visceral adipose tissue, and also potentially improve glucose metabolism
For example, in the SURPASS-2 study, TZP at the dose of 5, 10, and 15 mg reduced HbA1c by -2.18% vs -1.86% with semaglutide and weight by -9.3 kg vs -5.7 kg
Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH
Additionally, some individuals may experience an increased risk of hypoglycemia (low blood sugar) when taking semaglutide, particularly if they are also using insulin or other diabetes medications